AbCellera Biologics Cash Flow Statement 2018-2024 | ABCL

Fifteen years of historical annual cash flow statements for AbCellera Biologics (ABCL).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-146.40$159$153$119$-2.21$0.31
$30.89$33.10$17.25$5.27$1.85$0.73
$58.40$55.91$32.20$15.20$1.08$0.62
$89.30$89.02$49.45$20.47$2.93$1.35
$9.27$129$59.86$-203.02$-1.80$-0.48
$0$0$0$0$0$0
$-15.10$-2.09$-3.24$6.60$0.15$0.18
$-11.41$-8.64$-1.43$16.16$3.63$2.21
$13.23$29.83$41.67$-116.70$1.97$1.91
$-43.88$277$245$22.69$2.69$3.57
$-76.95$-70.66$-58.45$-9.67$-4.00$-5.31
$-0.56$-2.00$0.00$-5.00$0$0
$0$0$-11.46$-87.64$0$0
$-110.57$-253.35$-247.10$0$0$0
$-58.34$-43.05$-47.86$-17.46$0$0
$-168.91$-296.40$-294.96$-17.46$0$0
$25.31$16.43$32.62$0$-1.78$0
$-221.11$-352.63$-332.25$-119.78$-5.78$-5.31
$11.59$2.76$5.49$-3.45$-0.21$2.01
$0$0$0$89.99$0.39$-0.03
$11.59$2.76$5.49$86.54$0.18$1.98
$0$0$0$523$0.03$2.65
$0$0$0$598$0.01$10.21
$0$0$0$0$0$0
$-1.23$-4.38$-9.37$-0.39$0$0
$10.36$-1.63$-3.89$684$0.20$12.19
$-254.04$-86.49$-92.97$587$-2.89$10.44
$64.18$49.48$30.65$8.40$0.89$0.62
$0$0$0$0$0$0